Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval for Rezafungin for Candidemia and Invasive Candidiasis Treatment
Cidara Therapeutics and Melinta Therapeutics announced that the Antimicrobial Drugs Advisory Committee of the US Food and Drug Administration (FDA) authorised rezafungin to treat candidemia and invasi ...
Poxel SA Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
POXEL SA, a biotech company developing treatments for serious diseases, announces the European Commission grant of orphan drug designation for PXL770 and PXL065 for Adrenoleukodystrophy treatment. The ...